Loss of expression of the β subunit of soluble guanylyl cyclase prevents nitric oxide-mediated inhibition of DNA synthesis in smooth muscle cells of old rats

Circulation Research

Volumn 86, Issue 5, 2000, Pages 520-525

  Chen, Lihua ^a   Daum, Günter ^a   Fischer, Jens W ^a   Hawkins, Suzanne ^a   Bochaton Piallat, Marie Luce ^b   Gabbiani, Giulio ^b   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

CGMP; Hyperplasia; Nitric oxide; Smooth muscle cells; Soluble guanylyl cyclase

Indexed keywords

CYCLIC GMP; CYCLIC GMP DERIVATIVE; DNA; GUANYLATE CYCLASE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA INTIMA; AORTA MEDIA; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034677934     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.5.520     Document Type: Article

References (35)

1. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
2. Moncada S, Palmer RMJ, Higgs EA. NO: physiology, pathophysiology and pharmacology. Pharmocol Rev. 1991;43:109-142.
3. Koesling D, Bohme E, Schultz E. Guanylyl cyclases, a growing family of signal-transducing enzymes. FASEB J. 1991;5:2785-2791.
4. Loscalzo J, Welch G. Nitric oxide and its role in cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
5. Umans JG, Levi R. Nitric oxide in the regulation of blood flow and arterial pressure. Annu Rev Physiol. 1995;57:771-790.
6. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
7. Nakaki T, Nakayama M, Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol. 1990;189:347-353.
8. Chen L, Daum G, Forough R, Clowes M, Walter U, Clowes AW. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res. 1998;82:862-870.
9. Cooke JP, Singer AH, Tsao P, Zere P, Rowen RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
10. McNamara DB, Bedi B, Aurora H, Tena L, Ignarro LJ, Kadowitz PJ, Akers DL. L-Arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun. 1993;193:291-296.
11. Groves PH, Banning AP, Penny WJ, Newby AC, Cheadle HA, Lewis MJ. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res. 1995;30:87-96.
12. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.
13. Seki J, Nishio M, Kato Y, Motoyama Y, Yoshida K. FK409, a new nitric oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Atherosclerosis. 1995;117:97-106.
14. Schwarzacher SP, Lim TT, Wang B, Kernoff RS, Niebauer J, Cooke JP, Yeung AC. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation. 1997;95:1863-1869.
15. Garg UC, Hassid A. Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur J Pharmacol. 1993;237:243-249.
16. Murad F. What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle? Circulation. 1997;95:1101-1103.
17. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem. 1989;264:1146-1155.
18. Cornwell TL, Soff GA, Traynor AE, Lincoln TM. Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J Vasc Res. 1994;31:330-337.
19. Lincoln TM, Komalavilas P, Cornwell TL. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension. 1994;23:1141-1147.
20. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res. 1997;34:245-259.
21. Bilato C, Crow MT. Atherosclerosis and the vascular biology of aging. Aging (Miliano). 1996;8:221-234.
22. Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Garder R. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci U S A. 1982;79:3863-3866.
23. Hariri RJ, Hajjar DP, Coletti D, Alonso DR, Weksler ME, Rabellino E. Aging and arteriosclerosis: cell cycle kinetics of young and old arterial smooth muscle cells. Am J Pathol. 1988;131:132-136.
24. Hariri RJ, Alonso DR, Hajjar DP, Coletti D, Weksler ME. Aging and arteriosclerosis, I: development of myointimal hyperplasia after endothelial injury. J Exp Med. 1986;164:1171-1178.
25. McCaffrey TA, Nicholson AC, Szabo PE, Weksler ME, Weksler BB. Aging and arteriosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth-like activity. J Exp Med. 1988;167:163-174.
26. Bochaton-Piallat ML, Gabbiani F, Ropraz P, Gabbiani G. Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arterioscler Thromb. 1993;13:1449-1455.
27. Seger R, Ahn NG, Posada J, Munar ES, Jensen AM, Cooper JA, Cobb MH, Krebs EG. Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. J Biol Chem. 1992;267:14373-14381.
28. Halbrügge M, Friedrich C, Eigenthaler M, Schanzenbächer P, Walter U. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem. 1990;265:3088-3093.
29. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem. 1994;269:14509-14517.
30. Smolenski A, Bachmann C, Reinhard K, Hönig-Liedl P, Jarchau T, Hoschuetzky H, Walter U. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem. 1998;273: 20029-20035.
31. Foerster J, Harteneck C, Malkewitz J, Schultz G, Koesling DA. Functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits. Eur J Biochem. 1996;240: 380-386.
32. Vaandrager AB, de Jonge HR. Signalling by cGMP-dependent protein kinases. Mol Cell Biochem. 1996;157:23-30.
33. Hansson GK, Geng Y-J, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733-738.
34. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Arterioscler Thromb Vasc Biol. 1996;16:815-820.
35. Schwartz SM. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest. 1997;100:S87-S89.